Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data

Angiology

Volumn 65, Issue 6, 2014, Pages 543-550

  Theocharidou, Eleni ^a   Gossios, Thomas D ^b   Griva, Theodora ^a   Giouleme, Olga ^a   Douma, Stella ^a   Athyros, Vasilios G ^a   Karagiannis, Asterios ^a  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

atherosclerosis; C reactive protein; cardiovascular disease; carotid intima media thickness; inflammatory bowel disease

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; LABORATORY TEST; MALE; OBESITY; SEX DIFFERENCE; SMOKING; ULCERATIVE COLITIS; ADOLESCENT; AGE; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84903536238     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713489876     Document Type: Article

References (32)

1. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, et al. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol. 2010 ; 8 (4). 437-449
2. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349 ((25)). 2399-2406
3. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis Rheum. 2002 ; 46 ((4)). 862-873
4. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011 ; 140 (6). 1785-1794
5. Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008 ; 6 (1). 41-45
6. Ha C, Magowan S, Accortt NA, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009 ; 104 (6). 1445-1451
7. Haapamäki J, Roine RP, Turunen U, et al. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis. 2011 ; 5 (1). 41-47
8. Rungoe C, Basit S, Ranthe MF, et al. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut. 2012 ; 62 (5). 689-694
9. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol. 2004 ; 18 (3). 481-496
10. Cheng KS, Mikhailidis DP, Hamilton G, et al. A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res. 2002 ; 54 (3). 528-538
11. Daskalopoulou SS, Daskalopoulos ME, Mikhailidis DP, et al. Detection of early atherosclerosis using the ultrasound parameters of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidaemia. Int Angiol. 2005 ; 24 (4). 395
12. Tziomalos K, Athyros VG, Karagiannis A, et al. The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol. 2010 ; 25 (4). 394-398
13. Theocharidou E, Gossios TD, Giouleme O, et al. Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review. Angiology. 2014 ; 65 (4). 284-293
14. Dagli N, Poyrazoglu OK, Dagli AF, et al. Is inflammatory bowel disease a risk factor for early atherosclerosis?. Angiology. 2010 ; 61 (2). 198-204
15. Papa A, Santoliquido A, Danese S, et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005 ; 22 (9). 839-846
16. van Leuven SI, Hezemans R, Levels JH, et al. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J Lipid Res. 2007 ; 48 (12). 2640-2646
17. Broide E, Schopan A, Zaretsky M, et al. Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population. Dig Dis Sci. 2011 ; 56 (1). 197-202
18. Kayahan H, Sari I, Cullu N, et al. Evaluation of early atherosclerosis in patients with inflammatory bowel disease. Dig Dis Sci. 2012 ; 57 (8). 2137-2143
19. Maharshak N, Arbel Y, Bornstein NM, et al. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol. 2007 ; 102 (5). 1050-1055
20. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002 ; 122 (2). 512-530
21. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007 ; 132 (2). 763-786
22. Third Report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002 ; 106 (25). 3143-3421
23. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J. 2007 ; 28 (12). 1462-536
24. Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP. Do we need to consider inflammatory markers when we treat atherosclerotic disease?. Atherosclerosis. 2008 ; 200 (1). 1-12
25. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105 (9). 1135-1143
26. Toms TE, Panoulas VF, Douglas KM, et al. Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?. Angiology. 2011 ; 62 (2). 167-175
27. Ripolles PB, Nazih H, Bourreille A, et al. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism. 2006 ; 55 (7). 980-988
28. Principi M, Mastrolonardo M, Scicchitano P, et al. Endothelial function and cardiovascular risk in active inflammatory bowel diseases [published online March 6, 2013]. J Crohns Colitis. 2013 ;:
29. Aloi M, Tromba L, Di Nardo G, et al. Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr. 2012 ; 161 (4). 589-594
30. van der HF, Dijkstra A, Weersma RK, et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2009 ; 15 (8). 1199-1207
31. van der HF, Dijkstra A, Albersnagel FA, et al. Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis. J Crohns Colitis. 2010 ; 4 (2). 125-131
32. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation. 2006 ; 113 (17). 2128-2134